4
Changes in Ownership
Moleculin Biotech, Inc. Filed Acc 0001437749-23-017885
Chief Financial Officer gave up 3,044 shares (to pay taxes)
- Chief Financial Officer acquired 12,500 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Foster Jonathan P. Chief Financial Officer | 2023-06-16 | Option exercise | +12,500 | 23,623 | D: show line 1 in the form | ||
| Foster Jonathan P. Chief Financial Officer | 2023-06-16 | Shares withheld for taxes | −3,044 | $0.57 | $1,735 | 20,579 | D: show line 2 in the form |
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Foster Jonathan P. Chief Financial Officer | 2023-06-16 | Option exercise · Restricted Stock Units | −12,500 | 721,605 | D: show line 3 in the form |
Loading xslF345X04/rdgdoc.xml…